MedTrace Logo

Treatment of Dysmenorrhoea With the OVA TENS Apparatus

NCT00225836 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2007-01-17

No results posted yet for this study

Summary

Dysmenorrhoea (menstrual pain) is a common complaint among women, leading to use of analgesics, reduced quality of life, and interference with daily activities such as going to work or school.

Transcutaneous electrical nerve stimulation (TENS) is a well established method for treatment of pain. Several clinical studies have shown TENS treatment to be effective against dysmenorrhoea. A TENS apparatus specifically developed for the treatment of dysmenorrhoea has now become commercially available (OVA), but is has not been tested in clinical studies.

This study will be done to evaluate the clinical utility of treatment with OVA in women with primary dysmenorrhoea.

Conditions

  • Dysmenorrhoea

Interventions

DEVICE

OVA (TENS apparatus)

Sponsors & Collaborators

  • Vitacon AS, Vegamot 8, 7048 Trondheim, Norway

    collaborator UNKNOWN

  • The Hospital of Vestfold

    lead OTHER

Principal Investigators

  • Hjalmar A Schiotz, MD, PhD · Consultant Gynecologist, The Hospital of Vestfold, Tonsberg, Norway

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-09-30
Completion
2006-05-31

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00225836 on ClinicalTrials.gov